Investing 20 February 2026 - 21 February 2026

Lichen International Stock Trades Higher Ahead of Nasdaq Open
····

Lichen International Stock Trades Higher Ahead of Nasdaq Open

Lichen International Limited shares were up in early U.S. trading after a choppy Tuesday session. The small Nasdaq-listed China financial-services stock continued a strong move, though there was little new company news out to explain the demand. The stock traded at $1.52, up 14 cents, or about 10% over the last close, according to market data. Shares opened Tuesday at $1.32 and swung from $1.26 to $1.71, Yahoo Finance data showed. Volume was around 543,580 shares.
June 3, 2026
Lam Research stock price jumps on BofA “top pick” call — what LRCX investors watch next week
···

Lam Research stock price jumps on BofA “top pick” call — what LRCX investors watch next week

New York, Feb 21, 2026, 14:48 EST — The market wrapped up trading. Lam Research Corporation jumped 3.2% Friday, closing at $244.92—the strongest showing for the stock all week—after Bank of America singled out the chip-equipment maker just before next week’s trades kick in. Shares bounced between $236.68 and $245.70, with roughly 8.6 million changing hands. Applied Materials finished up 1.4%, KLA picked up 1.8%, and Nvidia tacked on nearly 1%.
February 21, 2026
GitLab stock (GTLB) sinks to $26 after a new 52-week low; Morgan Stanley cut sharpens March focus
···

GitLab stock (GTLB) sinks to $26 after a new 52-week low; Morgan Stanley cut sharpens March focus

NEW YORK, Feb 21, 2026, 10:06 EST — The market is now closed. GitLab ended Friday down 8.18% at $26.39, sliding to a 52-week low of $26.03 during the session as mid-cap software names continued to face heavy selling. Shares have lost roughly 59% in the past year and now hover just above the lower end of their 52-week range, which spans $26.03 to $64.42.
February 21, 2026
Johnson & Johnson stock slips as $20 billion DePuy sale talk grows — what investors watch next
···

Johnson & Johnson stock slips as $20 billion DePuy sale talk grows — what investors watch next

New York, Feb 20, 2026, 11:25 EST — Regular session Johnson & Johnson shares slipped 2.1% to $241.75 Friday morning, following a Reuters report that the healthcare giant is gearing up to sell its DePuy Synthes orthopedics business in a deal that could top $20 billion. DePuy Synthes generated $9.3 billion in sales in 2025, with products ranging from hip and knee implants to surgical tools and other devices.
February 20, 2026
1 … 20 21 22 23 24 … 32